Brief: Relmada Therapeutics Appoints Cns Therapeutic Expert Cedric O'gorman MD As Chief Medical Officer
09/01/2023 13:40
Relmada Therapeutics Inc RLMD.O :
* RELMADA THERAPEUTICS APPOINTS CNS THERAPEUTIC EXPERT
CEDRIC
O'GORMAN MD AS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nPnbfKBYla
Further company coverage: RLMD.O
Recent news on Relmada Therapeutics
See all newsRelmada Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Relmada Therapeutics Q2 EPS USD -0.11
Relmada Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia As Chief Business Officer
Brief: Relmada Therapeutics - Increases Authorized Common Stock To 200 Million Shares From 150 Million